In the S:t Göran ADHD project, individuals with attention deficit and hyperactivity disorder are carefully studied and followed over time. The aim is to improve diagnostics in ADHD and to increase our knowledge about the disorder. A long term aim is to identify biological markers to predict relapse, treatment response, cognitive and psychosocial function and quality of life in ADHD. Persons enrolled in the study undergo diagnostic, neuropsychological, and neuropsychiatric assessments as well as magnetic resonance imaging and cerebrospinal fluid analysis. In order to perform genetic analysis and to secure future research, wholeblood, serum, and cerebrospinal fluid samples are stored at KI Biobank.
The S:t Göran ADHD project enrolls patients who after careful clinical assessment receive a attention deficit (ADD/ ADHD) diagnosis and give written consent to participate in the study. Presently, patients are recruited at a specalized outpatient unit in Stockholm.
For more information about the S:t Göran ADHD study, please click here